Davids, M. S., Sharman, J. P., Eyre, T. A., Woyach, J. A., de Miranda, P. A. P., Shahkarami, M., Butturini, A., Emeribe, U., & Byrd, J. C. (2022). Contribution of Obinutuzumab to Acalabrutinib Therapy in Patients with Treatment-Naive Chronic Lymphocytic Leukemia: Analysis of Survival Outcomes By Genomic Features. Blood, 140(Supplement 1), 4173–4175. https://doi.org/10.1182/blood-2022-157018